BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20007580)

  • 1. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
    Weldon S; McNally P; McElvaney NG; Elborn JS; McAuley DF; Wartelle J; Belaaouaj A; Levine RL; Taggart CC
    J Immunol; 2009 Dec; 183(12):8148-56. PubMed ID: 20007580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A secretory leukocyte protease inhibitor variant with improved activity against lung infection.
    Camper N; Glasgow AM; Osbourn M; Quinn DJ; Small DM; McLean DT; Lundy FT; Elborn JS; McNally P; Ingram RJ; Weldon S; Taggart CC
    Mucosal Immunol; 2016 May; 9(3):669-76. PubMed ID: 26376365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
    Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
    J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
    Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
    J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.
    Sullivan AL; Dafforn T; Hiemstra PS; Stockley RA
    Respir Res; 2008 Aug; 9(1):60. PubMed ID: 18699987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor.
    Taggart CC; Lowe GJ; Greene CM; Mulgrew AT; O'Neill SJ; Levine RL; McElvaney NG
    J Biol Chem; 2001 Sep; 276(36):33345-52. PubMed ID: 11435427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender-related.
    Essilfie AT; Houston N; Maniam P; Hartel G; Okano S; Reid DW
    Respirology; 2023 Jun; 28(6):533-542. PubMed ID: 36642534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
    Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory Leucoprotease Inhibitor (SLPI) Promotes Survival during Acute
    Osbourn M; Rodgers AM; Dubois AV; Small DM; Humphries F; Delagic N; Moynagh PN; Weldon S; Taggart CC; Ingram RJ
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway.
    Cosgrove S; Chotirmall SH; Greene CM; McElvaney NG
    J Biol Chem; 2011 Mar; 286(9):7692-704. PubMed ID: 21193404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
    Sagel SD; Sontag MK; Accurso FJ
    Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein A enhances production of secretory leukoprotease inhibitor and protects it from cleavage by matrix metalloproteinases.
    Ramadas RA; Wu L; LeVine AM
    J Immunol; 2009 Feb; 182(3):1560-7. PubMed ID: 19155504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
    Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.
    Forde E; Humphreys H; Greene CM; Fitzgerald-Hughes D; Devocelle M
    Antimicrob Agents Chemother; 2014; 58(2):978-85. PubMed ID: 24277028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline.
    Bergsson G; Reeves EP; McNally P; Chotirmall SH; Greene CM; Greally P; Murphy P; O'Neill SJ; McElvaney NG
    J Immunol; 2009 Jul; 183(1):543-51. PubMed ID: 19542465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
    Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
    Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
    Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
    Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
    J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.